Aqueous Humor TGF-ß2 and Its Association With Intraocular Pressure in a Naturally Occurring Large Animal Model of Glaucoma.

Purpose: Transforming growth factor (TGF)-ß2 has been widely implicated in human glaucoma pathology. The purpose of this study was to determine the source of TGF-ß2 in aqueous humor (AH) and its relationship with intraocular pressure (IOP) in an inherited large animal model of glaucoma. Methods: Sixty-six glaucomatous cats homozygous for LTBP2 mutation, and 42 normal cats were studied. IOP was measured weekly by rebound tonometry. AH was collected by anterior chamber paracentesis from each eye under general anesthesia, and serum samples collected from venous blood concurrently. Concentrations of total, active and latent TGF-ß2 in AH and serum samples were measured by quantitative sandwich immunoassay. For comparisons between groups, unpaired t-test or Mann Whitney test were used, with P < 0.05 considered significant. The relationships between TGF-ß2 concentrations and IOP values were examined by Pearson's correlation coefficient and generalized estimating equation. Results: IOP and AH TGF-ß2 concentrations were significantly higher in glaucomatous than in normal cats. AH TGF-ß2 showed a significant, robust positive correlation with IOP in glaucomatous cats (r = 0.83, R2 = 0.70, P < 0.0001). Serum TGF-ß2 did not correlate with AH TGF-ß2 and was not significantly different between groups. TGF-ß2 mRNA and protein expression were significantly increased in local ocular tissues in glaucomatous cats. Conclusions: Enhanced, local ocular production of TGF-ß2 with a robust positive association with IOP was identified in this spontaneous feline glaucoma model, providing a foundation for preclinical testing of novel therapeutics to limit disease-associated AH TGF-ß2 elevation and signaling in glaucoma.

CT findings of nasal cryptococcosis in cats and dogs: A case series.

Cryptococcus spp. can cause chronic rhinitis in cats and dogs. Computed tomography (CT) descriptions of imaging features of nasal cryptococcosis are limited. This retrospective single-center consecutive case series aimed to describe the CT features of lesions in cats and dogs with nasal cryptococcosis. Ten cats and 12 dogs with a diagnosis of nasal cryptococcosis confirmed with cytology, histopathology, and/or serology that had undergone a head CT from 2010 and 2020 were included. Images were evaluated by a veterinary radiologist for the presence of a nasal or nasopharyngeal mass, regional destruction, intracranial extension, and lymphadenopathy. The majority of cats (8/10 [80%]) had nasal lesions with most cases described as non-destructive rhinitis (7/8 [88%]). Three cats (3/10 [30%]) had a nasal mass. All cats had a nasopharyngeal mass, and in most cases (8/10 [80%]) the nasopharyngeal mass was centered caudally near the temporomandibular joints. None of the cats had cribriform plate lysis or meningeal enhancement. All dogs had nasal lesions. Eleven dogs (11/12 [92%]) had destructive rhinitis with lysis of nasal conchae. Most dogs (8/12; 67%) had a nasal mass, of which in seven dogs the caudal nasal mass extended into the rostral nasopharynx. Most dogs had cribriform plate lysis (9/12 [75%]), of which four dogs (44%) had mass extension into the cranium. Our findings support potential differences in CT features between dogs and cats with nasal cryptococcosis. Nasal cryptococcosis should be considered a differential diagnosis in dogs and cats with nasal and nasopharyngeal masses.

Vaccination and Associated Adverse Events in Dogs Previously Treated for Primary Immune-Mediated Hemolytic Anemia.

This study described the rate of vaccine reactions in a population of dogs receiving vaccines after diagnosis of primary immune-mediated hemolytic anemia (IMHA). A secondary objective was to describe the time elapsed between vaccination and initial diagnosis of IMHA. A medical record search identified cases meeting criteria for primary IMHA. Owners and referring veterinarians were surveyed regarding vaccination of the dog following diagnosis. Referring veterinarians were surveyed regarding vaccination prior to diagnosis of IMHA. A completed survey was returned in 44 cases. Twenty-two dogs received vaccinations after diagnosis, and 22 dogs did not. The median time elapsed between vaccination and initial diagnosis was 280 days. No dog was vaccinated within 30 days of diagnosis. Two of the following possible reactions were noted out of 22 dogs vaccinated: vomiting and urticarial eruption in a dog administered a rabies and canine distemper vaccine, and recurrent anemia in a dog administered a rabies vaccine. The rate of vaccine reactions was higher than previously reported, although the time period evaluated was longer than in previous studies. The relationship between initial vaccination and development of IMHA, and between vaccination and vaccine reaction, in this population is uncertain and may reflect coincidence or differences in susceptibility.

Image-guided stereotactic radiotherapy in 4 dogs with intracranial neoplasia.

The purpose of this study was to describe the use, and side effects, of a novel stereotactic radiotherapy protocol using TomoTherapy(®) in 4 dogs with confirmed or suspected primary extra-axial intracranial neoplasia. Three fractions of 8 Gy were prescribed. Acute side effects were noted in 1 dog; no late effects were noted.

Radiothérapie stéréotactique guidée par imagerie chez 4 chiens atteints de néoplasie intracrâniale. Cette étude avait pour objectif de décrire l'utilisation et les effets secondaires d'un nouveau protocole de radiothérapie stéréotactique utilisant la TomoTherapyMD chez 4 chiens atteints de néoplasie intracrâniale extra-axiale primaire confirmée ou suspectée. Trois fractions de 8 Gy ont été prescrites. Des effets secondaires aigus ont été observés chez 1 chien; aucun effet tardif n'a été observé.(Traduit par Isabelle Vallières).